Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Acura Organics is a pharmaceutical company headquartered in Hyderabad, India, that specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. The company maintains a strong focus on antifungal therapeutic agents, producing high-quality generics such as Fluconazole, Ketoconazole, and Itraconazole for global markets. Acura Organics operates manufacturing facilities equipped to handle complex chemical syntheses, ensuring compliance with international quality standards and regulatory requirements. Beyond its standard product portfolio, the company offers custom synthesis and contract research and manufacturing services (CRAMS) to support the global pharmaceutical industry. By leveraging its expertise in process chemistry, Acura Organics provides cost-effective solutions for drug development and commercial-scale production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Acura Organics.